• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎:多器官视角。

COVID-19: a multi-organ perspective.

机构信息

Graduate Program in Biomedical Gerontology, School of Medicine, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, RS, Brazil.

Brain Institute of Rio Grande do Sul (BraIns), Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.

出版信息

Front Cell Infect Microbiol. 2024 Oct 18;14:1425547. doi: 10.3389/fcimb.2024.1425547. eCollection 2024.

DOI:10.3389/fcimb.2024.1425547
PMID:39492990
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11527788/
Abstract

In this mini review, we explore the complex network of inflammatory reactions incited by SARS-CoV-2 infection, which extends its reach well beyond the respiratory domain to influence various organ systems. Synthesizing existing literature, it elucidates how the hyperinflammation observed in COVID-19 patients affects multiple organ systems leading to physiological impairments that can persist over long after the resolution of infection. By exploring the systemic manifestations of this inflammatory cascade, from acute respiratory distress syndrome (ARDS) to renal impairment and neurological sequelae, the review highlights the profound interplay between inflammation and organ dysfunction. By synthesizing recent research and clinical observations, this mini review aims to provide an overview of the systemic interactions and complications associated with COVID-19, underscoring the need for an integrated approach to treatment and management. Understanding these systemic effects is crucial for improving patient outcomes and preparing for future public health challenges.

摘要

在这篇迷你综述中,我们探讨了由 SARS-CoV-2 感染引发的炎症反应的复杂网络,它的影响范围远远超出了呼吸系统,影响到各种器官系统。通过综合现有文献,我们阐明了 COVID-19 患者中观察到的过度炎症如何影响多个器官系统,导致生理损伤,即使在感染得到解决后仍会持续很长时间。通过探讨炎症级联反应的全身表现,从急性呼吸窘迫综合征(ARDS)到肾脏损伤和神经后遗症,本综述强调了炎症和器官功能障碍之间的深刻相互作用。通过综合最近的研究和临床观察,本迷你综述旨在概述与 COVID-19 相关的全身相互作用和并发症,强调需要采取综合治疗和管理方法。了解这些全身效应对于改善患者预后和为未来的公共卫生挑战做好准备至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19b2/11527788/49c7f73ce6ae/fcimb-14-1425547-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19b2/11527788/fbeb09cea8fc/fcimb-14-1425547-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19b2/11527788/3ecfb41701b7/fcimb-14-1425547-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19b2/11527788/49c7f73ce6ae/fcimb-14-1425547-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19b2/11527788/fbeb09cea8fc/fcimb-14-1425547-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19b2/11527788/3ecfb41701b7/fcimb-14-1425547-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19b2/11527788/49c7f73ce6ae/fcimb-14-1425547-g003.jpg

相似文献

1
COVID-19: a multi-organ perspective.新型冠状病毒肺炎:多器官视角。
Front Cell Infect Microbiol. 2024 Oct 18;14:1425547. doi: 10.3389/fcimb.2024.1425547. eCollection 2024.
2
Virus-Induced Acute Respiratory Distress Syndrome Causes Cardiomyopathy Through Eliciting Inflammatory Responses in the Heart.病毒诱导的急性呼吸窘迫综合征通过在心脏中引发炎症反应引起心肌病。
Circulation. 2024 Jul 2;150(1):49-61. doi: 10.1161/CIRCULATIONAHA.123.066433. Epub 2024 Mar 20.
3
Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.通过系统生物学方法和基于五个药物设计规范的 DNN-DTI 模型,重新利用多种分子药物治疗 COVID-19 相关急性呼吸窘迫综合征和非病毒性急性呼吸窘迫综合征。
Int J Mol Sci. 2022 Mar 26;23(7):3649. doi: 10.3390/ijms23073649.
4
Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review.新型冠状病毒病(COVID-19)所致急性呼吸窘迫综合征(ARDS):实用综合文献复习。
Expert Rev Respir Med. 2021 Feb;15(2):183-195. doi: 10.1080/17476348.2020.1820329. Epub 2020 Oct 18.
5
Transpulmonary pressure measurements and lung mechanics in patients with early ARDS and SARS-CoV-2.早期急性呼吸窘迫综合征和 SARS-CoV-2 患者的跨肺压测量和肺力学。
J Crit Care. 2021 Jun;63:106-112. doi: 10.1016/j.jcrc.2021.02.005. Epub 2021 Feb 25.
6
Neurological Complications of COVID-19: Unraveling the Pathophysiological Underpinnings and Therapeutic Implications.新型冠状病毒肺炎相关神经系统并发症:病理生理学基础与治疗意义。
Viruses. 2024 Jul 24;16(8):1183. doi: 10.3390/v16081183.
7
The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome.巨噬细胞在 SARS-CoV-2 相关急性呼吸窘迫综合征发病机制中的作用。
Front Immunol. 2021 May 10;12:682871. doi: 10.3389/fimmu.2021.682871. eCollection 2021.
8
Medium-Term Disability and Long-Term Functional Impairment Persistence in Survivors of Severe COVID-19 ARDS: Clinical and Physiological Insights.中重度残疾和长期功能障碍在重症 COVID-19 ARDS 幸存者中的持续存在:临床和生理学见解。
Arch Bronconeumol. 2024 Oct;60(10):619-626. doi: 10.1016/j.arbres.2024.05.021. Epub 2024 May 28.
9
Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword.细胞因子风暴与 COVID-19:一把双刃剑。
Front Immunol. 2021 Sep 30;12:742941. doi: 10.3389/fimmu.2021.742941. eCollection 2021.
10
Respiratory consequences after COVID-19: outcome and treatment.新冠病毒感染后的呼吸系统后果:结局和治疗。
Rev Esp Quimioter. 2022 Apr;35 Suppl 1(Suppl 1):67-72. doi: 10.37201/req/s01.16.2022. Epub 2022 Apr 22.

引用本文的文献

1
Clinical Features of SARS-CoV-2 Infected Patients in a Large Population Cohort from the South-West Region of Romania.罗马尼亚西南部地区一大群队列中感染新型冠状病毒2的患者的临床特征
Curr Health Sci J. 2024 Oct-Dec;50(4):498-507. doi: 10.12865/CHSJ.50.04.04. Epub 2024 Dec 31.
2
Serum albumin: a potential biomarker for liver involvement in SARS-CoV-2 infection.血清白蛋白:一种用于评估肝脏是否受累于新型冠状病毒2019感染的潜在生物标志物。
EBioMedicine. 2025 Feb;112:105565. doi: 10.1016/j.ebiom.2025.105565. Epub 2025 Jan 25.

本文引用的文献

1
The Aftermath of COVID-19: Exploring the Long-Term Effects on Organ Systems.新冠疫情的后果:探索对器官系统的长期影响
Biomedicines. 2024 Apr 20;12(4):913. doi: 10.3390/biomedicines12040913.
2
Recurrent ventilator-associated pneumonia in severe Covid-19 ARDS patients requiring ECMO support.在需要体外膜肺氧合(ECMO)支持的重症新型冠状病毒肺炎急性呼吸窘迫综合征(Covid-19 ARDS)患者中复发性呼吸机相关性肺炎。
Ann Intensive Care. 2024 Apr 25;14(1):67. doi: 10.1186/s13613-024-01295-1.
3
Cognition and Memory after Covid-19 in a Large Community Sample.新冠康复者的认知和记忆:一项大型社区样本研究。
N Engl J Med. 2024 Feb 29;390(9):806-818. doi: 10.1056/NEJMoa2311330.
4
Long-term risks of respiratory diseases in patients infected with SARS-CoV-2: a longitudinal, population-based cohort study.感染新型冠状病毒2的患者呼吸系统疾病的长期风险:一项基于人群的纵向队列研究。
EClinicalMedicine. 2024 Feb 17;69:102500. doi: 10.1016/j.eclinm.2024.102500. eCollection 2024 Mar.
5
Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus.新型冠状病毒肺炎中血管内皮激活、高凝和血栓形成的机制:与糖尿病的关联。
Cardiovasc Diabetol. 2024 Feb 20;23(1):75. doi: 10.1186/s12933-023-02097-8.
6
Risks of digestive diseases in long COVID: evidence from a population-based cohort study.长新冠患者发生消化系统疾病的风险:基于人群队列研究的证据。
BMC Med. 2024 Jan 10;22(1):14. doi: 10.1186/s12916-023-03236-4.
7
SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染会引发人类冠状动脉中的促动脉粥样硬化性炎症反应。
Nat Cardiovasc Res. 2023 Oct;2(10):899-916. doi: 10.1038/s44161-023-00336-5. Epub 2023 Sep 28.
8
Incidence and severity of pulmonary embolism in COVID-19 infection: Ancestral, Alpha, Delta, and Omicron variants.COVID-19 感染中肺栓塞的发生率和严重程度:原始株、阿尔法株、德尔塔株和奥密克戎株。
Medicine (Baltimore). 2023 Dec 1;102(48):e36417. doi: 10.1097/MD.0000000000036417.
9
Alveolar Hyperoxia and Exacerbation of Lung Injury in Critically Ill SARS-CoV-2 Pneumonia.肺泡性氧中毒与危重症 SARS-CoV-2 肺炎肺损伤加重。
Med Sci (Basel). 2023 Nov 1;11(4):70. doi: 10.3390/medsci11040070.
10
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review.肠道微生物群、肠道通透性和全身炎症:叙述性综述。
Intern Emerg Med. 2024 Mar;19(2):275-293. doi: 10.1007/s11739-023-03374-w. Epub 2023 Jul 28.